Printer Friendly

APROGENEX INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF COMMON STOCK

 HOUSTON, Aug. 10 /PRNewswire/ -- Aprogenex Inc. announced that it has filed a registration statement with the Securities and Exchange Commission covering a proposed initial public offering of 1,450,000 shares of newly issued common stock. The issue is expected to be priced between $10 and $12. H.J. Meyers & Co. Inc. will be the managing underwriter of the offering. The offering is expected in early October 1993.
 Aprogenex develops, manufactures and intends to market diagnostic test systems based on its proprietary DNA probe technology to identify the presence or extent of genetic abnormalities and disease. This Rightechnology utilizes the company's chemically manufactured probes and proprietary "cocktail" reagent solution which allows analysis of single intact cells at a molecular level. Using a maternal blood sample, one of the company's products is designed to identify the rare fetal cells circulating within the mother's blood and to permit the diagnosis of up to 95 percent of prenatal genetic abnormalities, such as Down Syndrome.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The offer is made only by the prospectus, a copy of which may be obtained from H.J. Meyers & Co Inc., 346 N. Camden Drive, Beverly Hills, CA 90210.
 -0- 8/10/93
 /CONTACT: J. Donald Payne of Aprogenex, 713-748-5114/


CO: Aprogenex Inc. ST: California IN: MTC SU: OFR

BP-LS -- LA003 -- 1071 08/10/93 09:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 10, 1993
Words:316
Previous Article:THE SILVERLAKES DEVELOPMENT AND G.L. HOMES ANNOUNCE MEGA-DEAL; G.L. HOMES TO BUY UP TO 2,790 LOTS FOR RESIDENTIAL CONSTRUCTION
Next Article:DAIN BOSWORTH FOUNDATION GRANTS $318,000 IN FIRST HALF
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters